Tag: VentureMed Group

VentureMed to present new data on DCB treatment for PAD

VentureMed Group has announced new data presentations on the treatment of peripheral arterial disease (PAD) with drug-coated balloon (DCBs) in addition to 12-month AV...
Flex Vessel Prep

VentureMed completes enrolment of Flex Vessel Prep system randomised controlled trial...

VentureMed Group recently announced that it has completed enrolment of a randomised controlled trial (RCT) titled 'Flex Vessel Prep prior to PTA for the...
VentureMed Flex

LINC 2021: Three studies evaluating Flex Vessel Prep system presented

VentureMed Group announced today that data from three studies evaluating the use of its Flex Vessel Prep (VP) system were presented during LINC 2021...
VentureMed Flex

Flex Vessel Prep system receives new indication to address in-stent restenosis

VentureMed Group recently announced that the US Food and Drug Administration (FDA) cleared the company's Flex Vessel Prep system for use in the treatment...

BELONG study enrols first patients

Enrolment of the first patients in the BELONG study—benefit of arterial vessel preparation by arterial by longitudinal micro-incisions before drug-eluting balloon angioplasty of the...
Venture Group Flex

Second iDissection Classification study to evaluate dissection rate of FLEX Dynamic...

VentureMed Group has announced the initiation of a new study to determine if the FLEX Dynamic Scoring Catheter reduces dissections and the need for...